PARP1 and familial pancreatic carcinoma: Here, we show that KP372-1-induced robust DNA damage response ensuing hyperactivation of DNA damage sensor protein poly(ADP-ribose) polymerase 1 (PARP1) offers a promising targeted chemotherapeutic strategy against pancreatic cancer.